Bluejay Diagnostics, Inc. 10-K Item 1C. Cybersecurity - 2026-03-06
Bluejay Diagnostics, Inc. disclosed their cybersecurity strategy, risk management and governance process in an annual SEC Filing 10-K filing on 2026-03-06 16:02:15 EST
Company Summary
Bluejay Diagnostics, Inc. develops rapid point-of-care diagnostic tests for critical care settings based on its Symphony technology platform (an analyzer and single-use cartridges), initially focusing on an IL-6 immunoassay for sepsis.
Filings
10-K filed on 2026-03-06
Bluejay Diagnostics, Inc. filed an SEC Filing 10-K filing on 2026-03-06 16:02:15 EST.
Accession Number: 0001213900-26-024616
Item 1C. Cybersecurity
Item 1C - Cybersecurity
We maintain various information security processes designed to identify, assess and manage material risks from cybersecurity threats.
Our President and Chief Executive Officer is responsible for overseeing our cybersecurity processes and works directly with third party service providers, as applicable, to identify , assess and manage the Company's cybersecurity threats and risks. In doing so, he seeks to identify and assess risks from cybersecurity threats in a manner appropriate for a company of comparable size and resources.
Our assessment and management of material risks from cybersecurity threats are integrated into the Company's overall risk management processes. For example, our IT Consulting Firm works with management to prioritize our risk management processes and mitigate cybersecurity threats that are more likely to lead to a material impact to our business.
Governance
Our Board of Directors addresses the Company's cybersecurity risk management as part of its general oversight function. The Board is responsible for overseeing Company's cybersecurity risk management processes. Our cybersecurity risk assessment and management processes are implemented and maintained by our President and Chief Executive Officer.
Our cybersecurity incident response and vulnerability management processes are designed to escalate certain cybersecurity incidents to members of management and/or the Board of Directors depending on the circumstances. The Board receives periodic reports and updates from our senior management concerning cybersecurity threats and risks, and the processes that the Company has implemented to address them.
We are not aware of any instances of material cybersecurity incidents that have impacted the Company.
Company
Profile
| Name | Bluejay Diagnostics, Inc. |
|---|---|
| CIK | 1704287 |
| SIC Description | |
| Industry | |
| Ticker | BJDX |
| Website | |
| Category | Non-accelerated Filer |
| Fiscal Year End | December 31 |